Hematology
Conference Coverage
EHR-based thromboembolism risk tool boosted prophylaxis
A thromboembolism risk calculator in a hospital’s EHR led to a significant rise in appropriate thromboprophylaxis and a drop in thromboembolic...
Feature
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
Conference Coverage
I am not fine: The heavy toll cancer takes
“I thought I was as exhausted, and isolated, and neglected as I could get, and then he came home.”
Conference Coverage
Blood test for multiple cancers: Many false positives
“This technology is not ready for population-wide screening, but as the technology improves, costs will go down.”
News
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
Conference Coverage
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in stroke
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic...
From the Journals
Blood biomarkers predict TBI disability and mortality
Measuring glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 proteins may give a more accurate assessment of a patient’s...
News from the FDA/CDC
FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic...
From the Journals
No more injections after one-off gene therapy in hemophilia B
“Normal factor IX levels can be achieved in patients with severe or moderately severe hemophilia B with the use of relatively low vector doses of...
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Opinion
Patients with blood cancers underutilize palliative care
Today in “Diminutio,” Sarah D’Ambruoso, NP, highlights this and other key presentations on palliative care from the ASCO annual meeting.